Immune System Balancing
[McCulley2018, pp 28, 35, 89, 275-285] reports that lupus is a
TH2-dominant, systemic,
autoimmune disorder, and proposes an approach to treating this disease, which should be
supervised by a properly trained medical professional.
Dr. Weyrich has considerable interest in this topic, but has
not treated any cases of lupus
with Immune System Balancing.
Dr. Weyrich notes that there are two forms of lupus: SLE (systemic) and DLE (discoid),
and that one is mediated by TH2 and the other is mediated by TH1.
This dialectic is also observed in Hansen's disease (leprosy).
Please see What is Immune System Balancing?
for more information.
Low Dose Naltrexone (LDN)
According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit
many different autoimmune diseases.
Dr. Bernard Bihari [Bihari2003], [Bihari2013 🕮 ],
who has successfully treated over 300 autoimmune cases, reports that
"all have experienced a halt in progression of their illness.
In many patients there was a marked remission in signs and symptoms of the disease."
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of lupus with LDN.
Please see What is Low Dose Naltrexone?
for more information.
Neurotransmitter Balancing
Neuro Research [Hinz2015] reports that
chronic diseases such as Discoid Lupus Erythematosus
can be benefited by balancing neurotransmitter levels in the body.
Dr. Weyrich has been trained in neurotransmitter balancing protocols, but has not treated
lupus using this technique.
Please see What is Neurotransmitter Balancing?
for more information.